healthprotocol.wiki
Protocols
Evidence
Outcomes
Home
/
Evidence
published-study_0000_cohort_glp-1-receptor-agonist-mcas-benefit-89-percent
1 finding
Protocol
medication-diabetes-glp-one-receptor-agonist-treatment
Outcome
immune-mast-cell-activation-syndrome-symptom-benefit-rate-89-percent-self-reported
n
47
effect
89
attribution
40
